-
Monitor and Acumen Research Highlights Why Impact Investing Needs Philanthropy
Today, we are thrilled to release From Blueprint to Scale: The Case for Philanthropy in Impact Investing, a new study by Monitor Group, in collaboration with Acumen, on the role of philanthropy in impact investing. From Blueprint to Scale is based on Monitor’s deep expertise, 60+ expert interviews and 10+ years of Acumen Fund data; it shows how grants are needed to bridge the gap when developing new business models that serve low income customers.
- Categories
- Uncategorized
-
At GPF 2012, Business and Philanthropy Mingle ‘Toward a New Social Contract’
For the past decade, the Global Philanthropy Forum has served as a catalyst for social change by bringing together donors and social investors with global leaders in business and government. This year’s forum is built around the theme “Toward a New Social Contract." In a recent interview, Jane Wales, president and CEO of the Global Philanthropy Forum and the World Affairs Council, discusses the shared value agenda.
- Categories
- Uncategorized
- Tags
- philanthropy
-
The Power to Give Strategically: Indian Philanthropy Forum by Dasra
The opulent Taj Mahal Palace hotel in Mumbai set the stage for high-net-worth individuals, socially-conscious investors and foundations, and corporate leaders to discuss the state of strategic giving in India. According to keynote speaker Matthew Bishop of The Economist, a “good billionaire” is increasingly becoming defined as one who, Bill Gates-style, thinks twice before simply writing a check.
- Categories
- Uncategorized
-
Narratives Are Not Enough
Many of you have been tracking the aftermath of the 60 Minutes report about Greg Mortenson?s non-profit, Central Asian Institute (CAI), the allegations of mismanagement and misrepresentations in his book, Three Cups of Tea. It shows how critical it is to collect actual data on how organizations impact poverty. How can we increase transparency?
- Categories
- Impact Assessment
-
Advancing Healthcare With the BoP: To Emerging Markets and Back Again
What happens when a large U.S.-based multinational company wants to get a product to market in the BoP? For Pfizer and GE, the approach is two-fold: part market-based and part philanthropic but both closely linked to market objectives of the firms.
- Categories
- Health Care
The Best of NextBillion in Your Inbox Each Week!
Subscribe to NB Notes for news, jobs & on-the-ground insights from the world of emerging markets business.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.